SingHealth Duke-NUS Academic Medical Centre

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau et al. · The Lancet · 2017 · 4.2K citations · Full text

Hepatology, Medicine, Expansion Trial +9

A single-cell and spatially resolved atlas of human breast cancers

Sunny Z. Wu, Ghamdan Al‐Eryani, Daniel Roden et al. · Nature Genetics · 2021 · 1.6K citations · Full text

Tumor Biology, Breast Oncology, Engineering +12

Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch et al. · European Journal of Immunology · 2019 · 965 citations · Full text

Laboratory Immunology, Immunology, Pathology +18

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore et al. · Cell · 2020 · 898 citations · Full text

Mild Covid-19, Hematological Malignancy, Hematology +5

Fate Mapping via Ms4a3-Expression History Traces Monocyte-Derived Cells

Zhaoyuan Liu, Yaqi Gu, Svetoslav Chakarov et al. · Cell · 2019 · 650 citations

Cell Lineage, Medicine, Fate Mapping +3